Article(id=1330183348560966411, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330183347923432202, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2023.01.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1665158400000, receivedDateStr=2022-10-08, revisedDate=1672329600000, revisedDateStr=2022-12-30, acceptedDate=null, acceptedDateStr=null, onlineDate=1795070023907, onlineDateStr=2026-11-19, pubDate=1673280000000, pubDateStr=2023-01-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795070023907, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795070023907, creator=13701087609, updateTime=1795070023907, updator=13701087609, issue=Issue{id=1330183347923432202, tenantId=1146029695717560320, journalId=1319690259887390882, year='2023', volume='54', issue='1', pageStart='1', pageEnd='164', issueExtLink='null', onlineDate='null', pubDate='1673280000000', pubDateStr='2023-01-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795070023755, creator='13701087609', updateTime=1795080415096, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330226933075390627, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330183347923432202, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330226933075390628, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330183347923432202, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1, endPage=18, ext={EN=ArticleExt(id=1330183348787458828, articleId=1330183348560966411, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Overviews of the New Drug in 2022 Approved by U.S. FDA, columnId=1327671169563603616, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Perspectives, runingTitle=null, highlight=null, articleAbstract=

The U.S. Food and Drug Administration(FDA) approved 37 new drugs into the market in 2022, including 22 chemical small molecules and 15 biological products. According to the prescription information for professionals and the related literature as well as patent information, this review describes the descriptions, indications, mechanism of action, dosage form and strength, adverse reactions, and one synthetic route of the chemical small molecules, and brief information about biological products.

, authors=Siju BI1, Kuaile LIN1, Lingling LIU2, Weicheng ZHOU1, *, authorsList=Siju BI, Kuaile LIN, Lingling LIU, Weicheng ZHOU, authorCompany=null, correspAuthors=Weicheng ZHOU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330183349433381649, articleId=1330183348560966411, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=2022年美国FDA批准上市的新药简介, columnId=1327671169823650466, journalTitle=中国医药工业杂志, columnName=专论, runingTitle=null, highlight=null, articleAbstract=

2022年美国食品药品监督管理局(Food and Drug Administration,FDA)批准上市新药37个,其中化学小分子22个、生物制品15个。该研究根据FDA批准的新药说明书以及相关文献和专利情况,简要介绍化学小分子药物的概况、适应证、作用机制、剂型规格、不良反应和合成路线等,以及生物制品的相关情况。

, authors=毕思举1, 林快乐1, 刘玲玲2, 周伟澄1, *, authorsList=毕思举, 林快乐, 刘玲玲, 周伟澄, authorCompany=null, correspAuthors=周伟澄, authorNote=

周伟澄,博士,荣获“第四届中国青年科技奖”“国家级有突出贡献的中青年科技专家”“上海市优秀学科带头人”和“上海市领军人才”等称号;享受国务院特殊津贴;上海医药工业研究院研究员,博士生导师,《中国医药工业杂志》总编辑;上海交通大学药学院兼职教授,复旦大学药学院博士生导师。研究课题多次受到联合国开发署/世界银行/世界卫生组织、国家科技攻关项目、国家重大新药创制、国家973项目等的资助。获国家一类新药证书1份,其他类别新药证书5份。国家授权专利60多项。主编《高等药物化学选论》《化学药物制备的工业化技术》两本研究生教科书,由化学工业出版社出版。发表论文190多篇,培养博士研究生(已毕业)27人,硕士研究生39人。

毕思举(1993—),男,博士研究生,专业方向:药物化学。

, correspAuthorsNote=
周伟澄(1958—),男,研究员,博士生导师,从事药物化学研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=V1XxoXMvlluDIqsQ4Hi7Kg==, magXml=yeAw/WlD7ehhFrX8uwMVug==, pdfUrl=null, pdf=Rv60GErmAPdqffRJXcwJdA==, pdfFileSize=3153012, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=At8lMsHam6pV+AOBMgycRQ==, mapNumber=null, fund=null)}, authors=[Author(id=1330183349823451929, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330183349911532315, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, authorId=1330183349823451929, language=EN, stringName=Siju BI, firstName=Siju, middleName=null, lastName=BI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183349999612700, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, authorId=1330183349823451929, language=CN, stringName=毕思举, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海 201203, bio={"content":"

毕思举(1993—),男,博士研究生,专业方向:药物化学。

"}, bioImg=null, bioContent=

毕思举(1993—),男,博士研究生,专业方向:药物化学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183349617931026, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, xref=1., ext=[AuthorCompanyExt(id=1330183349626319635, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, companyId=1330183349617931026, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330183349634708244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, companyId=1330183349617931026, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海 201203)])]), Author(id=1330183350066721566, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330183350146413344, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, authorId=1330183350066721566, language=EN, stringName=Kuaile LIN, firstName=Kuaile, middleName=null, lastName=LIN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183350205133601, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, authorId=1330183350066721566, language=CN, stringName=林快乐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183349617931026, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, xref=1., ext=[AuthorCompanyExt(id=1330183349626319635, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, companyId=1330183349617931026, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330183349634708244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, companyId=1330183349617931026, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海 201203)])]), Author(id=1330183350272242467, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330183350351934245, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, authorId=1330183350272242467, language=EN, stringName=Lingling LIU, firstName=Lingling, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.China National Pharmaceutical Informational Center, Shanghai 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183350414848806, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, authorId=1330183350272242467, language=CN, stringName=刘玲玲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.中国医药工业信息中心,上海 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183349710205717, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, xref=2., ext=[AuthorCompanyExt(id=1330183349718594326, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, companyId=1330183349710205717, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.China National Pharmaceutical Informational Center, Shanghai 200040), AuthorCompanyExt(id=1330183349726982935, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, companyId=1330183349710205717, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业信息中心,上海 200040)])]), Author(id=1330183350477763368, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhouweicheng58@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330183350565843754, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, authorId=1330183350477763368, language=EN, stringName=Weicheng ZHOU, firstName=Weicheng, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183350645535531, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, authorId=1330183350477763368, language=CN, stringName=周伟澄, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183349617931026, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, xref=1., ext=[AuthorCompanyExt(id=1330183349626319635, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, companyId=1330183349617931026, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330183349634708244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, companyId=1330183349617931026, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海 201203)])])], keywords=[Keyword(id=1330183350742004524, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, language=EN, orderNo=1, keyword=U.S. FDA), Keyword(id=1330183352369394477, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, language=EN, orderNo=2, keyword=new drug approval), Keyword(id=1330183352465863470, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, language=EN, orderNo=3, keyword=indication), Keyword(id=1330183352524583727, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, language=EN, orderNo=4, keyword=synthetic route), Keyword(id=1330183352604275504, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, language=CN, orderNo=1, keyword=美国FDA), Keyword(id=1330183352683967281, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, language=CN, orderNo=2, keyword=新药批准), Keyword(id=1330183352763659058, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, language=CN, orderNo=3, keyword=适应证), Keyword(id=1330183352830767923, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, language=CN, orderNo=4, keyword=合成路线)], refs=[Reference(id=1330183352931431220, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=刘潍源,林快乐,刘玲玲,等.2021年美国FDA批准上市的新药简介[J].中国医药工业杂志,2021,53(1):1-27., articleTitle=null, refAbstract=null), Reference(id=1330183353002734389, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Novel drug approvals for 2022 [EB/OL]. (2022-12-29)[2023-01-01]. https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2022., articleTitle=null, refAbstract=null), Reference(id=1330183353074037558, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=TAKESHI S, SATORU I, SACHIE O, et al. Preparation of 3,5-disubstituted alkynylbenzene compounds as FGFR inhibitors: WO, 2013108809A1 [P]. 2013-01-17., articleTitle=null, refAbstract=null), Reference(id=1330183353149535031, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=WILLIAM A D, LEE A C, BLANCHARD S, et al. Discovery of the macrocycle 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19. 3. 1. 1(2,6). 1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a potent Janus kinase 2/FMS-like tyrosine kinase-3(JAK2/FLT3) inhibitor for the treatment of myelofibrosis and lymphoma [J]. J Med Chem, 2011,54(13): 4638-4658., articleTitle=null, refAbstract=null), Reference(id=1330183353216643896, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=CARAVELLA J A, LIN J, DIEBOLD R B, et al. Structure-based design and identification of FT-2102(olutasidenib), a potent mutant-selective IDH1 inhibitor [J]. J Med Chem,2020, 63(4): 1612-1623., articleTitle=null, refAbstract=null), Reference(id=1330183353296335673, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=FELL J B, FISCHER J P, BAER B R, et al. Identification of the clinical development candidate MRTX849, a covalent KRASG12C inhibitor for the treatment of cancer [J]. J Med Chem, 2020, 63(13): 6679-6693., articleTitle=null, refAbstract=null), Reference(id=1330183353363444538, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=克里斯托弗 B,克里斯汀 P,马库斯 G,等.苯并咪唑脯氨酸衍生物:中国,104334544B [P].2015-02-04., articleTitle=null, refAbstract=null), Reference(id=1330183353430553403, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=何明华,廖清江.加那索酮的合成[J].中国新药杂志,2005,14(8):1025-1026., articleTitle=null, refAbstract=null), Reference(id=1330183353497662268, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=PARENTI M. Process for the preparation of tauroursode-oxycholic acid: WO, 2008128844A1 [P]. 2007-04-23., articleTitle=null, refAbstract=null), Reference(id=1330183353560576829, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=陈庚辉,韦伯斯特 J M,李建雄,等.抗发炎、治疗牛皮癣和抑制蛋白质致活酶的羟基芪、芪衍生物及类似物:WO,2001042231 [P].2001-06-14., articleTitle=null, refAbstract=null), Reference(id=1330183353623491390, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=TREITLER D S, SOUMEILLANT M C, SIMMONS E M, et al. Development of a commercial process for deucravacitinib, a deuterated API for TYK2 inhibition [J]. Org Process Res Dev, 2022, 26(4): 1202-1222., articleTitle=null, refAbstract=null), Reference(id=1330183353711571775, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=胡克斯特拉 W J,耶茨 K M,本克 M,等.抗真菌化合物的制备方法:中国,106458900B [P].2017-02-22., articleTitle=null, refAbstract=null), Reference(id=1330183353820623680, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=ARIKAWA Y, NISHIDA H, KURASAWA O, et al. Discovery of a novel pyrrole derivative 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine fumarate(TAK-438) as a potassium-competitive acid blocker(PCAB)[J]. J Med Chem, 2012,55(9): 4446-4456., articleTitle=null, refAbstract=null), Reference(id=1330183353883538241, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=萨德斯 J O,撒力图如颜顺启 F G.治疗性化合物和组合物:中国,102481300B [P].2010-06-29., articleTitle=null, refAbstract=null), Reference(id=1330183353967424322, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=CONONR C G, DEFOREST J C, DIETRICH P, et al. Development of a nitrene-type rearrangement for the commercial route of the JAK1 inhibitor abrocitinib [J]. Org Process Res Dev, 2021, 25(3): 608-615., articleTitle=null, refAbstract=null), Reference(id=1330183354026144579, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=奥斯洛布 J,安德森 R,奥贝勒 D,等.针对心脏病症的嘧啶二酮化合物:中国,105473576B [P].2016-04-06., articleTitle=null, refAbstract=null), Reference(id=1330183354084864837, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=萩原昌彦,岩村亮,柴川信彦,等.取代羰基化合物:中国,102948985A [P].2010-09-10., articleTitle=null, refAbstract=null), Reference(id=1330183354168750918, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=LINK J O, RHEE M S, TSE W C, et al. Clinical targeting of HIV capsid protein with a long-acting small molecule [J]. Nature, 2020, 584(7822): 614-618., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330183349617931026, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, xref=1., ext=[AuthorCompanyExt(id=1330183349626319635, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, companyId=1330183349617931026, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330183349634708244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, companyId=1330183349617931026, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海 201203)]), AuthorCompany(id=1330183349710205717, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, xref=2., ext=[AuthorCompanyExt(id=1330183349718594326, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, companyId=1330183349710205717, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.China National Pharmaceutical Informational Center, Shanghai 200040), AuthorCompanyExt(id=1330183349726982935, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, companyId=1330183349710205717, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业信息中心,上海 200040)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.01.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2023.01.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2023.01.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2023.01.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1673280000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
2022年美国FDA批准上市的新药简介
毕思举 1 , 林快乐 1 , 刘玲玲 2 , 周伟澄 1, *
中国医药工业杂志 | 专论 2023,54(1): 1-18
收起
收藏切换
中国医药工业杂志 |专论 2023 , 54 (1) : 1 -18
2022年美国FDA批准上市的新药简介
全屏
[Author(id=1330183349823451929, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330183349911532315, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, authorId=1330183349823451929, language=EN, stringName=Siju BI, firstName=Siju, middleName=null, lastName=BI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183349999612700, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, authorId=1330183349823451929, language=CN, stringName=毕思举, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海 201203, bio={"content":"

毕思举(1993—),男,博士研究生,专业方向:药物化学。

"}, bioImg=null, bioContent=

毕思举(1993—),男,博士研究生,专业方向:药物化学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183349617931026, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, xref=1., ext=[AuthorCompanyExt(id=1330183349626319635, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, companyId=1330183349617931026, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330183349634708244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, companyId=1330183349617931026, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海 201203)])]), Author(id=1330183350066721566, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330183350146413344, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, authorId=1330183350066721566, language=EN, stringName=Kuaile LIN, firstName=Kuaile, middleName=null, lastName=LIN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183350205133601, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, authorId=1330183350066721566, language=CN, stringName=林快乐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183349617931026, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, xref=1., ext=[AuthorCompanyExt(id=1330183349626319635, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, companyId=1330183349617931026, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330183349634708244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, companyId=1330183349617931026, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海 201203)])]), Author(id=1330183350272242467, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330183350351934245, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, authorId=1330183350272242467, language=EN, stringName=Lingling LIU, firstName=Lingling, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.China National Pharmaceutical Informational Center, Shanghai 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183350414848806, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, authorId=1330183350272242467, language=CN, stringName=刘玲玲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.中国医药工业信息中心,上海 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183349710205717, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, xref=2., ext=[AuthorCompanyExt(id=1330183349718594326, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, companyId=1330183349710205717, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.China National Pharmaceutical Informational Center, Shanghai 200040), AuthorCompanyExt(id=1330183349726982935, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, companyId=1330183349710205717, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业信息中心,上海 200040)])]), Author(id=1330183350477763368, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhouweicheng58@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330183350565843754, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, authorId=1330183350477763368, language=EN, stringName=Weicheng ZHOU, firstName=Weicheng, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183350645535531, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, authorId=1330183350477763368, language=CN, stringName=周伟澄, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183349617931026, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, xref=1., ext=[AuthorCompanyExt(id=1330183349626319635, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, companyId=1330183349617931026, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330183349634708244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183348560966411, companyId=1330183349617931026, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海 201203)])])]
毕思举1, 林快乐1, 刘玲玲2, 周伟澄1, *
作者信息
  • 1.中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海 201203
  • 2.中国医药工业信息中心,上海 200040
通讯作者:
周伟澄(1958—),男,研究员,博士生导师,从事药物化学研究。E-mail:
作者简介:

周伟澄,博士,荣获“第四届中国青年科技奖”“国家级有突出贡献的中青年科技专家”“上海市优秀学科带头人”和“上海市领军人才”等称号;享受国务院特殊津贴;上海医药工业研究院研究员,博士生导师,《中国医药工业杂志》总编辑;上海交通大学药学院兼职教授,复旦大学药学院博士生导师。研究课题多次受到联合国开发署/世界银行/世界卫生组织、国家科技攻关项目、国家重大新药创制、国家973项目等的资助。获国家一类新药证书1份,其他类别新药证书5份。国家授权专利60多项。主编《高等药物化学选论》《化学药物制备的工业化技术》两本研究生教科书,由化学工业出版社出版。发表论文190多篇,培养博士研究生(已毕业)27人,硕士研究生39人。

毕思举(1993—),男,博士研究生,专业方向:药物化学。

Overviews of the New Drug in 2022 Approved by U.S. FDA
Siju BI1, Kuaile LIN1, Lingling LIU2, Weicheng ZHOU1, *
Affiliations
  • 1.State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203
  • 2.China National Pharmaceutical Informational Center, Shanghai 200040
出版时间: 2023-01-10 doi: 10.16522/j.cnki.cjph.2023.01.001
文章导航
收藏切换

2022年美国食品药品监督管理局(Food and Drug Administration,FDA)批准上市新药37个,其中化学小分子22个、生物制品15个。该研究根据FDA批准的新药说明书以及相关文献和专利情况,简要介绍化学小分子药物的概况、适应证、作用机制、剂型规格、不良反应和合成路线等,以及生物制品的相关情况。

美国FDA  /  新药批准  /  适应证  /  合成路线

The U.S. Food and Drug Administration(FDA) approved 37 new drugs into the market in 2022, including 22 chemical small molecules and 15 biological products. According to the prescription information for professionals and the related literature as well as patent information, this review describes the descriptions, indications, mechanism of action, dosage form and strength, adverse reactions, and one synthetic route of the chemical small molecules, and brief information about biological products.

U.S. FDA  /  new drug approval  /  indication  /  synthetic route
毕思举, 林快乐, 刘玲玲, 周伟澄. 2022年美国FDA批准上市的新药简介. 中国医药工业杂志, 2023 , 54 (1) : 1 -18 . DOI: 10.16522/j.cnki.cjph.2023.01.001
Siju BI, Kuaile LIN, Lingling LIU, Weicheng ZHOU. Overviews of the New Drug in 2022 Approved by U.S. FDA[J]. Chinese Journal of Pharmaceuticals, 2023 , 54 (1) : 1 -18 . DOI: 10.16522/j.cnki.cjph.2023.01.001

参考文献 引证文献
排序方式:
[1]
刘潍源,林快乐,刘玲玲,等.2021年美国FDA批准上市的新药简介[J].中国医药工业杂志,2021,53(1):1-27.
[3]
TAKESHI S, SATORU I, SACHIE O, et al. Preparation of 3,5-disubstituted alkynylbenzene compounds as FGFR inhibitors: WO, 2013108809A1 [P]. 2013-01-17.
[4]
WILLIAM A D, LEE A C, BLANCHARD S, et al. Discovery of the macrocycle 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19. 3. 1. 1(2,6). 1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a potent Janus kinase 2/FMS-like tyrosine kinase-3(JAK2/FLT3) inhibitor for the treatment of myelofibrosis and lymphoma [J]. J Med Chem, 2011,54(13): 4638-4658.
[5]
CARAVELLA J A, LIN J, DIEBOLD R B, et al. Structure-based design and identification of FT-2102(olutasidenib), a potent mutant-selective IDH1 inhibitor [J]. J Med Chem,2020, 63(4): 1612-1623.
[6]
FELL J B, FISCHER J P, BAER B R, et al. Identification of the clinical development candidate MRTX849, a covalent KRASG12C inhibitor for the treatment of cancer [J]. J Med Chem, 2020, 63(13): 6679-6693.
[7]
克里斯托弗 B,克里斯汀 P,马库斯 G,等.苯并咪唑脯氨酸衍生物:中国,104334544B [P].2015-02-04.
[8]
何明华,廖清江.加那索酮的合成[J].中国新药杂志,2005,14(8):1025-1026.
[9]
PARENTI M. Process for the preparation of tauroursode-oxycholic acid: WO, 2008128844A1 [P]. 2007-04-23.
[10]
陈庚辉,韦伯斯特 J M,李建雄,等.抗发炎、治疗牛皮癣和抑制蛋白质致活酶的羟基芪、芪衍生物及类似物:WO,2001042231 [P].2001-06-14.
[11]
TREITLER D S, SOUMEILLANT M C, SIMMONS E M, et al. Development of a commercial process for deucravacitinib, a deuterated API for TYK2 inhibition [J]. Org Process Res Dev, 2022, 26(4): 1202-1222.
[12]
胡克斯特拉 W J,耶茨 K M,本克 M,等.抗真菌化合物的制备方法:中国,106458900B [P].2017-02-22.
[13]
ARIKAWA Y, NISHIDA H, KURASAWA O, et al. Discovery of a novel pyrrole derivative 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine fumarate(TAK-438) as a potassium-competitive acid blocker(PCAB)[J]. J Med Chem, 2012,55(9): 4446-4456.
[14]
萨德斯 J O,撒力图如颜顺启 F G.治疗性化合物和组合物:中国,102481300B [P].2010-06-29.
[15]
CONONR C G, DEFOREST J C, DIETRICH P, et al. Development of a nitrene-type rearrangement for the commercial route of the JAK1 inhibitor abrocitinib [J]. Org Process Res Dev, 2021, 25(3): 608-615.
[16]
奥斯洛布 J,安德森 R,奥贝勒 D,等.针对心脏病症的嘧啶二酮化合物:中国,105473576B [P].2016-04-06.
[17]
萩原昌彦,岩村亮,柴川信彦,等.取代羰基化合物:中国,102948985A [P].2010-09-10.
[18]
LINK J O, RHEE M S, TSE W C, et al. Clinical targeting of HIV capsid protein with a long-acting small molecule [J]. Nature, 2020, 584(7822): 614-618.
2023年第54卷第1期
30
10
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2023.01.001
  • 接收时间:2022-10-08
  • 首发时间:2026-11-19
  • 出版时间:2023-01-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-10-08
  • 修回日期:2022-12-30
基金
作者信息
    1.中国医药工业研究总院上海医药工业研究院,创新药物与制药工艺国家重点实验室,上海 201203
    2.中国医药工业信息中心,上海 200040

通讯作者:

周伟澄(1958—),男,研究员,博士生导师,从事药物化学研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.01.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏